---
title: "Librexia ACS — Pfizer (Acute Coronary Syndrome) | Amavita Research"
url: https://md.amavitaresearch.com/trials/librexia-acs
canonical: https://www.amavitaresearch.com/trials/librexia-acs
schema_type: MedicalTrial
last_updated: 2026-05-12
---

# Librexia ACS

**Phase 3 cardiovascular trial at Amavita Research (Miami).**

- Sponsor: Pfizer
- Protocol: C4921003
- Indication: Acute Coronary Syndrome (ACS)

## How to engage

- Sponsors / CROs: srubio@amavita.health · https://www.amavitaresearch.com/contact-sponsor
- Patients (eligibility): (786) 703-5941 · https://www.amavitaresearch.com/contact-patient